BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 15741166)

  • 1. Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells.
    Miralem T; Hu Z; Torno MD; Lelli KM; Maines MD
    J Biol Chem; 2005 Apr; 280(17):17084-92. PubMed ID: 15741166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliverdin reductase, a novel regulator for induction of activating transcription factor-2 and heme oxygenase-1.
    Kravets A; Hu Z; Miralem T; Torno MD; Maines MD
    J Biol Chem; 2004 May; 279(19):19916-23. PubMed ID: 14988408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The coordinated increased expression of biliverdin reductase and heme oxygenase-2 promotes cardiomyocyte survival: a reductase-based peptide counters β-adrenergic receptor ligand-mediated cardiac dysfunction.
    Ding B; Gibbs PE; Brookes PS; Maines MD
    FASEB J; 2011 Jan; 25(1):301-13. PubMed ID: 20876213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human biliverdin reductase is a leucine zipper-like DNA-binding protein and functions in transcriptional activation of heme oxygenase-1 by oxidative stress.
    Ahmad Z; Salim M; Maines MD
    J Biol Chem; 2002 Mar; 277(11):9226-32. PubMed ID: 11773068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin.
    Jansen T; Hortmann M; Oelze M; Opitz B; Steven S; Schell R; Knorr M; Karbach S; Schuhmacher S; Wenzel P; Münzel T; Daiber A
    J Mol Cell Cardiol; 2010 Aug; 49(2):186-95. PubMed ID: 20430037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliverdin reductase: new features of an old enzyme and its potential therapeutic significance.
    Florczyk UM; Jozkowicz A; Dulak J
    Pharmacol Rep; 2008; 60(1):38-48. PubMed ID: 18276984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of heme oxygenase-1 gene expression by MAP kinases of the JNK and p38 pathways in primary cultures of rat hepatocytes.
    Kietzmann T; Samoylenko A; Immenschuh S
    J Biol Chem; 2003 May; 278(20):17927-36. PubMed ID: 12637567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein/protein interactions in the mammalian heme degradation pathway: heme oxygenase-2, cytochrome P450 reductase, and biliverdin reductase.
    Spencer AL; Bagai I; Becker DF; Zuiderweg ER; Ragsdale SW
    J Biol Chem; 2014 Oct; 289(43):29836-58. PubMed ID: 25196843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.
    Barone E; Di Domenico F; Mancuso C; Butterfield DA
    Neurobiol Dis; 2014 Feb; 62():144-59. PubMed ID: 24095978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of heme oxygenase-1, biliverdin reductase and H-ferritin in lung macrophage in smokers with primary spontaneous pneumothorax: role of HIF-1alpha.
    Goven D; Boutten A; Leçon-Malas V; Marchal-Sommé J; Soler P; Boczkowski J; Bonay M
    PLoS One; 2010 May; 5(5):e10886. PubMed ID: 20526373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited role for the bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase.
    Maghzal GJ; Leck MC; Collinson E; Li C; Stocker R
    J Biol Chem; 2009 Oct; 284(43):29251-9. PubMed ID: 19690164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential application of biliverdin reductase and its fragments to modulate insulin/IGF-1/MAPK/PI3-K signaling pathways in therapeutic settings.
    Maines MD
    Curr Drug Targets; 2010 Dec; 11(12):1586-94. PubMed ID: 20704544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heme-oxygenase-1-induced protection against hypoxia/reoxygenation is dependent on biliverdin reductase and its interaction with PI3K/Akt pathway.
    Pachori AS; Smith A; McDonald P; Zhang L; Dzau VJ; Melo LG
    J Mol Cell Cardiol; 2007 Nov; 43(5):580-92. PubMed ID: 17920074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human heme oxygenase-1 efficiently catabolizes heme in the absence of biliverdin reductase.
    Reed JR; Huber WJ; Backes WL
    Drug Metab Dispos; 2010 Nov; 38(11):2060-6. PubMed ID: 20679134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells.
    Kitamuro T; Takahashi K; Ogawa K; Udono-Fujimori R; Takeda K; Furuyama K; Nakayama M; Sun J; Fujita H; Hida W; Hattori T; Shirato K; Igarashi K; Shibahara S
    J Biol Chem; 2003 Mar; 278(11):9125-33. PubMed ID: 12511571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The heme oxygenase/biliverdin reductase system in skin cancers.
    Arena V; Pennacchia I; Guerriero G; Mancuso C
    J Biol Regul Homeost Agents; 2015; 29(1):259-64. PubMed ID: 25864768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the tyrosine phosphorylation pathway in induction of human heme oxygenase-1 by hemin, sodium arsenite, and cadmium chloride.
    Masuya Y; Hioki K; Tokunaga R; Taketani S
    J Biochem; 1998 Sep; 124(3):628-33. PubMed ID: 9722676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer's disease.
    Di Domenico F; Pupo G; Mancuso C; Barone E; Paolini F; Arena A; Blarzino C; Schmitt FA; Head E; Butterfield DA; Perluigi M
    J Alzheimers Dis; 2015; 44(4):1107-20. PubMed ID: 25391381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells. Role of mitogen-activated protein kinases.
    Elbirt KK; Whitmarsh AJ; Davis RJ; Bonkovsky HL
    J Biol Chem; 1998 Apr; 273(15):8922-31. PubMed ID: 9535875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner.
    Salinas M; Diaz R; Abraham NG; Ruiz de Galarreta CM; Cuadrado A
    J Biol Chem; 2003 Apr; 278(16):13898-904. PubMed ID: 12578834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.